495 related articles for article (PubMed ID: 14745734)
1. Frequent EpCam protein expression in human carcinomas.
Went PT; Lugli A; Meier S; Bundi M; Mirlacher M; Sauter G; Dirnhofer S
Hum Pathol; 2004 Jan; 35(1):122-8. PubMed ID: 14745734
[TBL] [Abstract][Full Text] [Related]
2. Epithelial cell adhesion molecule expression (CD326) in cancer: a short review.
Patriarca C; Macchi RM; Marschner AK; Mellstedt H
Cancer Treat Rev; 2012 Feb; 38(1):68-75. PubMed ID: 21576002
[TBL] [Abstract][Full Text] [Related]
3. Subtypes of cervical adenosquamous carcinomas classified by EpCAM expression related to radiosensitivity.
Imadome K; Iwakawa M; Nakawatari M; Fujita H; Kato S; Ohno T; Nakamura E; Ohkubo Y; Tamaki T; Kiyohara H; Imai T
Cancer Biol Ther; 2010 Nov; 10(10):1019-26. PubMed ID: 20855955
[TBL] [Abstract][Full Text] [Related]
4. Expression of epithelial cell adhesion molecule (EpCam) in renal epithelial tumors.
Went P; Dirnhofer S; Salvisberg T; Amin MB; Lim SD; Diener PA; Moch H
Am J Surg Pathol; 2005 Jan; 29(1):83-8. PubMed ID: 15613858
[TBL] [Abstract][Full Text] [Related]
5. Epithelial cell adhesion molecule (KSA) expression: pathobiology and its role as an independent predictor of survival in renal cell carcinoma.
Seligson DB; Pantuck AJ; Liu X; Huang Y; Horvath S; Bui MH; Han KR; Correa AJ; Eeva M; Tze S; Belldegrun AS; Figlin RA
Clin Cancer Res; 2004 Apr; 10(8):2659-69. PubMed ID: 15102668
[TBL] [Abstract][Full Text] [Related]
6. Impact of the EpCAM expression on biochemical recurrence-free survival in clinically localized prostate cancer.
Benko G; Spajić B; Krušlin B; Tomas D
Urol Oncol; 2013 May; 31(4):468-74. PubMed ID: 21514185
[TBL] [Abstract][Full Text] [Related]
7. EpCAM expression in primary tumour tissues and metastases: an immunohistochemical analysis.
Spizzo G; Fong D; Wurm M; Ensinger C; Obrist P; Hofer C; Mazzoleni G; Gastl G; Went P
J Clin Pathol; 2011 May; 64(5):415-20. PubMed ID: 21415054
[TBL] [Abstract][Full Text] [Related]
8. Prognostic and diagnostic implications of epithelial cell adhesion/activating molecule (EpCAM) expression in renal tumours: a retrospective clinicopathological study of 948 cases using tissue microarrays.
Zimpfer A; Maruschke M; Rehn S; Kundt G; Litzenberger A; Dammert F; Zettl H; Stephan C; Hakenberg OW; Erbersdobler A
BJU Int; 2014 Aug; 114(2):296-302. PubMed ID: 24215118
[TBL] [Abstract][Full Text] [Related]
9. Loss of membranous expression of the intracellular domain of EpCAM is a frequent event and predicts poor survival in patients with pancreatic cancer.
Fong D; Moser P; Kasal A; Seeber A; Gastl G; Martowicz A; Wurm M; Mian C; Obrist P; Mazzoleni G; Spizzo G
Histopathology; 2014 Apr; 64(5):683-92. PubMed ID: 24117877
[TBL] [Abstract][Full Text] [Related]
10. Epithelial cell adhesion molecule is an independent prognostic marker in clear cell renal carcinoma.
Eichelberg C; Chun FK; Bedke J; Heuer R; Adam M; Moch H; Terracciano L; Hinrichs K; Dahlem R; Fisch M; Schlomm T; Sauter G; Minner S
Int J Cancer; 2013 Jun; 132(12):2948-55. PubMed ID: 23180689
[TBL] [Abstract][Full Text] [Related]
11. EpCAM Aptamer-siRNA Chimera Targets and Regress Epithelial Cancer.
Subramanian N; Kanwar JR; Kanwar RK; Sreemanthula J; Biswas J; Khetan V; Krishnakumar S
PLoS One; 2015; 10(7):e0132407. PubMed ID: 26176230
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological implications of EpCAM expression in adenocarcinoma of the lung.
Kim Y; Kim HS; Cui ZY; Lee HS; Ahn JS; Park CK; Park K; Ahn MJ
Anticancer Res; 2009 May; 29(5):1817-22. PubMed ID: 19443410
[TBL] [Abstract][Full Text] [Related]
13. Expression of epithelial cell adhesion molecule in paired tumor samples of patients with primary and recurrent serous ovarian cancer.
Pietzner K; Woopen H; Richter R; Joens T; Braicu EI; Dimitrova D; Mellstedt H; Darb-Esfahani S; Denkert C; Lindhofer H; Fotopoulou C; Sehouli J
Int J Gynecol Cancer; 2013 Jun; 23(5):797-802. PubMed ID: 23694980
[TBL] [Abstract][Full Text] [Related]
14. Expression of epithelial cell adhesion molecule in gallbladder carcinoma and its correlation with clinicopathologic variables.
Prince S; Zeidman A; Dekel Y; Ram E; Koren R
Am J Clin Pathol; 2008 Mar; 129(3):424-9. PubMed ID: 18285265
[TBL] [Abstract][Full Text] [Related]
15. Selective gene delivery toward gastric and esophageal adenocarcinoma cells via EpCAM-targeted adenoviral vectors.
Heideman DA; Snijders PJ; Craanen ME; Bloemena E; Meijer CJ; Meuwissen SG; van Beusechem VW; Pinedo HM; Curiel DT; Haisma HJ; Gerritsen WR
Cancer Gene Ther; 2001 May; 8(5):342-51. PubMed ID: 11477454
[TBL] [Abstract][Full Text] [Related]
16. EpCAM: A new therapeutic target for an old cancer antigen.
Armstrong A; Eck SL
Cancer Biol Ther; 2003; 2(4):320-6. PubMed ID: 14508099
[TBL] [Abstract][Full Text] [Related]
17. EpCAM expression in squamous cell carcinoma of the oral cavity: frequency and relationship to clinicopathologic features.
Laimer K; Fong D; Gastl G; Obrist P; Kloss F; Tuli T; Gassner R; Rasse M; Norer B; Spizzo G
Oral Oncol; 2008 Jan; 44(1):72-7. PubMed ID: 17418618
[TBL] [Abstract][Full Text] [Related]
18. Identification of DNA aptamers toward epithelial cell adhesion molecule via cell-SELEX.
Kim JW; Kim EY; Kim SY; Byun SK; Lee D; Oh KJ; Kim WK; Han BS; Chi SW; Lee SC; Bae KH
Mol Cells; 2014 Oct; 37(10):742-6. PubMed ID: 25266702
[TBL] [Abstract][Full Text] [Related]
19. EpCAM expression in the prostate cancer makes the difference in the response to growth factors.
Yoshida GJ; Saya H
Biochem Biophys Res Commun; 2014 Jan; 443(1):239-45. PubMed ID: 24309103
[TBL] [Abstract][Full Text] [Related]
20. Effect of EpCAM, CD44, CD133 and CD166 expression on patient survival in tumours of the ampulla of Vater.
Piscuoglio S; Lehmann FS; Zlobec I; Tornillo L; Dietmaier W; Hartmann A; Wünsch PH; Sessa F; Rümmele P; Baumhoer D; Terracciano LM
J Clin Pathol; 2012 Feb; 65(2):140-5. PubMed ID: 22130902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
